ASPIRIANT, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1433541 San Francisco, CA

Position in REGN

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$289,946

+$34,975 QoQ

Shares Held

465

+40.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#954

of 1,322 holders

Holding Since

Sep 2023

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

ASPIRIANT, LLC holds $4,288,646 across 3 Biotechnology names. REGN ranks #3 (6.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RYTM	Rhythm Pharmaceuticals, Inc.	27,960	$3,104,398
2	PVLA	Palvella Therapeutics, Inc.	5,852	$894,302
3	REGN	Regeneron Pharmaceuticals, Inc. This page	465	$289,946

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$289,946	465	+40.9%	Shares	Sole	2026-07-20
2026-03-31	$254,971	330	-17.3%	Shares	Sole	2026-05-12
2025-12-31	$307,976	399	+9.6%	Shares	Sole	2026-01-20
2025-03-31	$230,859	364	-5.9%	Shares	Sole	2025-04-21
2024-12-31	$275,671	387	+14.5%	Shares	Sole	2025-01-16
2024-09-30	$355,319	338	-4.0%	Shares	Sole	2024-10-17
2024-06-30	$369,962	352	-11.6%	Shares	Sole	2024-07-15
2024-03-31	$383,071	398	0.0%	Shares	Sole	2024-04-15
2023-12-31	$349,559	398	+16.4%	Shares	Sole	2024-01-26
2023-09-30	$281,452	342	—	Shares	Sole	2023-10-18
No filing history on record for this holder in this stock.